Fundamentals and stats

Saniona AB is a clinical-stage biopharmaceutical company, which engages in the research and development on drugs for diseases of the central nervous system, autoimmune diseases, and metabolic diseases. Its research focuses on ion channels, which are made up of protein that enables and controls the passage of charged ions across cell membranes. Its product pipeline includes Tesofensine, Tesomet, SAN2219, SAN2465, and SAN903. The company was founded by Claus Tycho Bræstrup, Anker Gunvald Lundemose, Jørgen Drejer, Palle Christophersen, Thomas Feldthus, and Janus Schreiber Larsen in 2011 and is headquartered Glostrup, Denmark.